Related references
Note: Only part of the references are listed.GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity
Michael A. Spinner et al.
BLOOD (2014)
The evolution of cellular deficiency in GATA2 mutation
Rachel E. Dickinson et al.
BLOOD (2014)
A Remote GATA2 Hematopoietic Enhancer Drives Leukemogenesis in inv(3)(q21;q26) by Activating EVI1 Expression
Hiromi Yamazaki et al.
CANCER CELL (2014)
A Single Oncogenic Enhancer Rearrangement Causes Concomitant EVI1 and GATA2 Deregulation in Leukemia
Stefan Groeschel et al.
CELL (2014)
Acquired ASXL1 mutations are common in patients with inherited GATA2 mutations and correlate with myeloid transformation
Robert R. West et al.
HAEMATOLOGICA (2014)
Flow cytometric differentiation of abnormal and normal plasma cells in the bone marrow in patients with multiple myeloma and its precursor diseases
Prashant R. Tembhare et al.
LEUKEMIA RESEARCH (2014)
The inverted CD4/CD8 ratio and associated parameters in 66-year-old individuals: the Swedish HEXA immune study
J. Strindhall et al.
AGE (2013)
Bone Marrow Findings in HIV-Positive Patients With Kaposi Sarcoma Herpesvirus-Associated Multicentric Castleman Disease
Girish Venkataraman et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2013)
High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia
Marlene Pasquet et al.
BLOOD (2013)
GATA2 haploinsufficiency caused by mutations in a conserved intronic element leads to MonoMAC syndrome
Amy P. Hsu et al.
BLOOD (2013)
Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature
Jan Kazenwadel et al.
BLOOD (2012)
MonoMAC and GATA2 deficiency: overlapping clinical and pathological features with aplastic anemia and idiopathic CD4+ lymphocytopenia. Reply to Haematologica. 2012;97(4):058669
Katherine R. Calvo et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Cis-element mutated in GATA2-dependent immunodeficiency governs hematopoiesis and vascular integrity
Kirby D. Johnson et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Myelodysplastic Syndrome With inv(3)(q21q26.2) or t(3;3)(q21;q26.2) Has a High Risk for Progression to Acute Myeloid Leukemia
Wei Cui et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2011)
Successful allogeneic hematopoietic stem cell transplantation for GATA2 deficiency
Jennifer Cuellar-Rodriguez et al.
BLOOD (2011)
Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency
Rachel Emma Dickinson et al.
BLOOD (2011)
Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome
Amy P. Hsu et al.
BLOOD (2011)
Myelodysplasia in autosomal dominant and sporadic monocytopenia immunodeficiency syndrome: diagnostic features and clinical implications
Katherine R. Calvo et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency
Venetia Bigley et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
De novo acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2): a clinicopathologic and cytogenetic study of an entity recently added to the WHO classification
Jianlan Sun et al.
MODERN PATHOLOGY (2011)
Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome)
Pia Ostergaard et al.
NATURE GENETICS (2011)
Heritable GATA2 mutations associated with familial myelodysplastic syndrome and acute myeloid leukemia
Christopher N. Hahn et al.
NATURE GENETICS (2011)
Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia
Donald C. Vinh et al.
BLOOD (2010)
Graded repression of PU.1/Sfpi1 gene transcription by GATA factors regulates hematopoietic cell fate
Stella T. Chou et al.
BLOOD (2009)
Diagnostic criteria to distinguish hypocellular acute myeloid leukemia from hypocellular myelodysplastic syndromes and aplastic anemia: recommendations for a standardized approach
John M. Bennett et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
GATA-2 Reinforces Megakaryocyte Development in the Absence of GATA-1
Zan Huang et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Hematogones are markedly reduced in pediatric acquired aplastic anemia: multiparametric flow cytometric analysis
Deborah W. Sevilla et al.
LEUKEMIA & LYMPHOMA (2009)
Immunohistochemical Evaluation of 95 Bone Marrow Reactive Plasmacytoses
Maria G. Ioannou et al.
PATHOLOGY & ONCOLOGY RESEARCH (2009)
Multiparameter flow cytometric analysis reveals low percentage of bone marrow hematogones in myelodysplastic syndromes
Sepideh Maftoun-Banankhah et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
Quantitative analysis of bone marrow CD34 cells in aplastic anemia and hypoplastic myelodysplastic syndromes
WH Matsui et al.
LEUKEMIA (2006)
Haploinsufficiency of GATA-2 perturbs adult hematopoietic stem-cell homeostasis
NP Rodrigues et al.
BLOOD (2005)
In-vivo dominant immune responses in aplastic anaemia:: molecular tracking of putatively pathogenetic T-cell clones by TCR β-CDR3 sequencing
AM Risitano et al.
LANCET (2004)
GATA-2 plays two functionally distinct roles during the ontogeny of hematopoietic stem cells
KW Ling et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
The distribution of gene segments in T-cell receptor γ gene rearrangements demonstrates the need for multiple primer sets
LC Lawnicki et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2003)
Selective reduction of natural killer T cells in the bone marrow of aplastic anaemia
WH Zeng et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Cooperative and antagonistic interplay between PU.1 and GATA-2 in the specification of myeloid cell fates
JC Walsh et al.
IMMUNITY (2002)
Roles of hematopoietic transcription factors GATA-1 and GATA-2 in the development of red blood cell lineage
K Ohneda et al.
ACTA HAEMATOLOGICA (2002)
Expression of transcription factors during magakaryocytic differentiation of CD34+cells from human cord blood induced by thrombopoietin.
K Terui et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2000)